IMMU-21. DEVELOPMENT OF PET TRACERS FOR NON-INVASIVE IMAGING OF IMMUNOTHERAPY IN DIFFUSE INTRINSIC PONTINE GLIOMA

DIPG is an incurable brain tumor with median overall survival times of less than 10 months, with current treatment. Immunotherapy is an attractive approach for some DIPG patients based on promising clinical and preclinical studies. However, due to surgical inaccessibility, intratumoral heterogeneity...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Nigam, Shubhanchi, McCarl, Lauren, Anderson, Carolyn, Panigrahy, Ashok, Pollack, Ian, Edwards, Barry, Kohanbash, Gary
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Immunology/Immunotherapy
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477296/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.140
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg